The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy.

Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy.

The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.

CD4 Count Recovery After Initiation of Antiretroviral Therapy in Patients Infected With Human Immunodeficiency Virus.

CD4 Cell Count: Declining Value for Antiretroviral Therapy Eligibility.

Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.

Clinical monitoring and high-risk conditions among patients with SUD newly prescribed opioids and benzodiazepines.

mm3.

Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa.

Increase in CD4 count among new enrollees in HIV care in the modern antiretroviral therapy era.

Total Lymphocyte Count and Haemoglobin Concentration Combined as a Surrogate Marker for Initiating Highly Active Antiretroviral Therapy in a Resource-limited Setting as against CD4 Cell Count.

Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.

Routine CD4 cell count monitoring seldom contributes to clinical decision-making on antiretroviral therapy in virologically suppressed HIV-infected patients.

CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy.

High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy.

CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda.

Long-term CD4+ cell count in response to combination antiretroviral therapy.

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy.

The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study.

Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.

Status of immunity against PVB19 in HIV-infected patients according to CD4(+) cell count, and antiretroviral therapy regimen groups.

Genital HSV Shedding among Kenyan Women Initiating Antiretroviral Therapy.

Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study.

CD8 Cell Ratio in Acute HIV Infection and the Impact of Early Antiretroviral Therapy.

CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis.

Suggest Documents

Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy.

The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.

CD4 Count Recovery After Initiation of Antiretroviral Therapy in Patients Infected With Human Immunodeficiency Virus.

CD4 Cell Count: Declining Value for Antiretroviral Therapy Eligibility.

Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.

Clinical monitoring and high-risk conditions among patients with SUD newly prescribed opioids and benzodiazepines.

mm3.

Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa.

Increase in CD4 count among new enrollees in HIV care in the modern antiretroviral therapy era.

Total Lymphocyte Count and Haemoglobin Concentration Combined as a Surrogate Marker for Initiating Highly Active Antiretroviral Therapy in a Resource-limited Setting as against CD4 Cell Count.

Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.

Routine CD4 cell count monitoring seldom contributes to clinical decision-making on antiretroviral therapy in virologically suppressed HIV-infected patients.

CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy.

High Current CD4+ T Cell Count Predicts Suboptimal Adherence to Antiretroviral Therapy.

CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda.

Long-term CD4+ cell count in response to combination antiretroviral therapy.

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy.

The impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort study.

Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana.

Status of immunity against PVB19 in HIV-infected patients according to CD4(+) cell count, and antiretroviral therapy regimen groups.

Genital HSV Shedding among Kenyan Women Initiating Antiretroviral Therapy.

Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study.

CD8 Cell Ratio in Acute HIV Infection and the Impact of Early Antiretroviral Therapy.

CD4 changes among virologically suppressed patients on antiretroviral therapy: a systematic review and meta-analysis.

The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy.

Recommend Documents

Follow Us